Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GBA1 | P04062 | 5/20 | 0.54 |
| ▸ | GJB2 | P29033 | 4/20 | 0.54 |
| ▸ | TNF | P01375 | 1/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.49 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.49 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.49 |
| ▸ | MGAM | O43451 | 2/20 | 0.41 |
| ▸ | SI | P14410 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19681968 | 1.00 | GBA1 (0.54) | GBA1GJB2TNFMAPK1LGALS8 | |
| SCHEMBL19678133 | 1.00 | GBA1 (0.54) | GBA1GJB2TNFMAPK1LGALS8 | |
| SCHEMBL17857935 | 1.00 | GBA1 (0.54) | GBA1GJB2TNFMAPK1LGALS8 | |
| SCHEMBL19682033 | 1.00 | GBA1 (0.54) | GBA1GJB2TNFMAPK1LGALS8 | |
| SCHEMBL19678117 | 1.00 | GBA1 (0.54) | GBA1GJB2TNFMAPK1LGALS8 | |
| SCHEMBL22390598 | 1.00 | GBA1 (0.54) | GBA1GJB2TNFMAPK1LGALS8 | |
| SCHEMBL22390606 | 1.00 | GBA1 (0.54) | GBA1GJB2TNFMAPK1LGALS8 | |
| SCHEMBL22390602 | 1.00 | GBA1 (0.54) | GBA1GJB2TNFMAPK1LGALS8 | |
| SCHEMBL22404764 | 1.00 | GBA1 (0.54) | GBA1GJB2TNFMAPK1LGALS8 | |
| SCHEMBL19678132 | 1.00 | GBA1 (0.54) | GBA1GJB2TNFMAPK1LGALS8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170347653-A1 | ANTIBACTERIAL COMPOSITION CONTAINING AN ISOMER MIXTURE OF MONOSACCHARIDE ALKYL MONOACETALS OR MONOETHERS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2017-12-07 | — | — | US | disclosed |
| US-20170347653-A1 | ANTIBACTERIAL COMPOSITION CONTAINING AN ISOMER MIXTURE OF MONOSACCHARIDE ALKYL MONOACETALS OR MONOETHERS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2017-12-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170347653-A1 | ANTIBACTERIAL COMPOSITION CONTAINING AN ISOMER MIXTURE OF MONOSACCHARIDE ALKYL MONOACETALS OR MONOETHERS | GNE, MGAM, GALE | GBA1 216/4885GJB2 3588/4885TNF 1776/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.